Biogen Inc. 8-K Report: Key Corporate Updates as of July 31, 2025

Here is the key information extracted from the provided section of the financial report:

1. Entity Information:

• Company Name: Biogen Inc.
• State of Incorporation: Delaware (DE)
• SEC CIK: 0000875045
• IRS Employer Identification Number (EIN): 33-0112644
• Address: 225 Binney Street, Cambridge, MA 02142
• Phone Number: 617-679-2000

2. Filing Information:

• Filing Type: 8-K (current report used to disclose major events that shareholders should know about)
• Filing Date: July 31, 2025

3. Stock Information:

• Common Stock: $0.0005 par value
• Ticker Symbol: BIIB
• Exchange: NASDAQ

4. Period of Report:

• Report Date: July 31, 2025 (this appears to be both the start and end date for the reported period)

Insights:

• Biogen Inc. is providing a current report (8-K) which typically indicates significant corporate events or changes, suggesting there may be important updates or disclosures for investors.
• The company's common stock is traded on NASDAQ under the ticker symbol BIIB, which is relevant for shareholders and potential investors looking to track market performance.
• The report specifies a single-day report date, indicating that the information disclosed may pertain to an event or circumstance occurring on that specific date rather than over a longer reporting period.

This financial report section primarily serves to inform stakeholders about key corporate updates and operational details relevant to Biogen Inc. as of the end date specified.